Market Place
Sourcing Support
Sun Pharma Highlights Dermatology Portfolio at Fall Conference
25 Oct 2024 //
PR NEWSWIRE
Sun Pharma`s WINLEVI® Cream Reduces Sebum Levels in Acne
25 Oct 2024 //
PR NEWSWIRE
FDA Confirms Para IV Patent Litigation for (Winlevi) Clascoterone
09 Oct 2024 //
FDA
Sun Pharma receives approval for Winlevi in Australia
20 Mar 2024 //
INDIANPHARMAPOST
Sun Pharma Canada launches Prwinlevi for treatment for acne
28 Sep 2023 //
INDIAN PHARMA POST
Hyphens Pharma licenses Winlevi for acne improvement in 10 countries
26 Dec 2022 //
BIOSPECTRUMASIA
Sun Pharma Presents Phase 3 Data for WINLEVI cream 1% for Acne Vulgaris at AAD
25 Mar 2022 //
PRNEWSWIRE
Sun Pharma Announces Availability of WINLEVI®
01 Nov 2021 //
PRESS RELEASE
Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi
26 Jul 2021 //
PRESS RELEASE
Sun Pharma signs license agreement with Cassiopea SpA for Winlevi in US & Canada
26 Jul 2021 //
PHARMABIZ
Cassiopea SpA’s Signing of License and Supply Agreements for Winlevi
26 Jul 2021 //
PRESS RELEASE
Sun Pharma signs license agreement with Cassiopea SpA for Winlevi in US & Canada
26 Jul 2021 //
PHARMABIZ
AMRI Named Exclusive API Supplier for Recently Approved Acne Treatment
30 Oct 2020 //
BUSINESSWIRE
Cassiopea gets FDA approval for acne treatment Winlevi
28 Aug 2020 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.